课题基金 / 基金详情

A novel stem cell transplantation for refractory leukemia using HLA-haploidentical grafts

A novel stem cell transplantation for refractory leukemia using HLA-haploidentical grafts
使用 HLA-半相合移植物进行新型干细胞移植治疗难治性白血病
批准号:
18591090
负责人:
OGAWA Hiroyasu
金额:
$2.57万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2006
资助国家:
日本
项目状态:
已结题
起止时间:
2006 至 2007

项目摘要

项目成果

OGAWA Hiroyasu的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Allogeneic stem cell transplantation requires an HLA-identical sibling. However, only about 25% of patients who need allogeneic stem cell transplantation (SCT) have such a donor. Thus, an HLA-haploidentical (2-3 antigen-mismatched) donor has been considered as an alternative donor. In unmanipulated HLA-haploidentical SCT, severe graft-versus-host disease (GVHD) is a major problem. Production of inflammatory cytokine in the peritransplantation period is a key factor for developing GVHD. We have planned to overcome severe GVHD through suppressing the production of cytokines by reducing intensity of conditioning treatment (nonmyeloablative), or by a use of intensified GVHD prophylaxis containing steroids.In nonmyeloablative SCT using an HLA-haploidentical donor, we reported a 96.2% engraftment rate and 20% incidence of severe GVHD (Biol Blood Marrow Tr, 2006; 12: 1073). Furthermore, In HLA-haploidentical myeloablative SCT using intensified GVHD prophylaxis containing steroids, we obtained … More a 100% engraftment rate and a 36.7% incidence of severe GVHD (Exp Hematol, 2008: 36: 1). These results indicated that unmanipulated HLA-haploidentical SCT was feasible.In order to clarify the pathophysiology of engraftment or GVHD in HLA-haploidentical SCT, we developed murine MHC-mismatched bone marrow transplantation system (B6C3F1(H-2^<b/k>)→BDF1(H-2^<b/d>)). In this system, recipient mice did or did not develop fatal GVHD depending on total body irradiation dose. We analyzed the kinetics of, and the characteristics of, donor T cells in secondary lymphoid organs, including spleen and lymph nodes as well as in GVHD-target organs, including small and large intestines, liver and skin. As a result, GVHD mice were found to have massive invasive donor T cells in involved organs, although there was no difference in the extent of proliferation of T cells in secondary lymphoid organs between GVHD and non-GVHD mice. Thus, GVHD was found to occur depending on the extent of inflammation of GVHD-target organs. Less
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DOI: 10.3892/ijmm.20.2.241
发表时间: 2007-08
期刊: International journal of molecular medicine
影响因子: 5.4
作者: [Yuka Fujibayashi;Y. Fujimori;Ikuyo Kasumoto;S. Kai;H. Hara;H. Okamura;H. Tsutsui;H. Ogawa;K. Nakanishi]
通讯作者: Yuka Fujibayashi;Y. Fujimori;Ikuyo Kasumoto;S. Kai;H. Hara;H. Okamura;H. Tsutsui;H. Ogawa;K. Nakanishi
Diffuse Large B-cell lymphoma showing interfollicular pattern of proliferation : A study of the Osaka Lymphoma Study Group.
显示滤泡间增殖模式的弥漫性大 B 细胞淋巴瘤:大阪淋巴瘤研究组的一项研究。
DOI: --
发表时间: 2008
期刊: Histopathology 52
影响因子: --
作者: [Yamauchi A, Ogawa H, et. al.]
通讯作者: et. al.
Different kinetics of the WT1 and PML-RARα gene expression levels during remission induction therapy with all-trans reinoic acid alone in acute promyelocytic leukaemia.
急性早幼粒细胞白血病单独使用全反式视黄酸缓解诱导治疗期间 WT1 和 PML-RARα 基因表达水平的不同动力学。
DOI: --
发表时间: 2006
期刊: International Journal of Hematology 85・5
影响因子: --
作者: [Tamaki H, Ogawa H, et al.]
通讯作者: et al.
移植後髄外再発の部位診断におけるPET-CTの有用性
PET-CT在诊断移植后髓外复发部位中的作用
DOI: --
发表时间: 2008
期刊:
影响因子: --
作者: [吉原 哲, 小川 啓恭, 他]
通讯作者:
56
    Study of HLA-haploidentical stem cell transplantation that enables high graft-versus-leukemia effects
    • 批准号:
      16K09882
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.0万
    • 财政年份:
      2016
    • 负责人:
      OGAWA Hiroyasu
    • 依托单位:
    Establishment of safety of HLA-haploidentical stem cell transplantation
    • 批准号:
      21591252
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.91万
    • 财政年份:
      2009
    • 负责人:
      OGAWA Hiroyasu
    • 依托单位:
    Wilms tumor gene(WT1)expression in leukemic and normal hematopoietic stem cells.
    • 批准号:
      09671110
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.92万
    • 财政年份:
      1997
    • 负责人:
      OGAWA Hiroyasu
    • 依托单位:
    海外基金